Holding(s) in Company TR-1: Standard form for notification

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
38
Holding(s) in Company

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
 
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:Summit Therapeutics PLC
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an “X” if appropriate)
  
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsX
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rights 
Other (please specify)iii: 
3. Details of person subject to the notification obligationiv
NamePolar Capital LLP
City and country of registered office (if applicable) 
4. Full name of shareholder(s) (if different from 3.)v
Name 
City and country of registered office (if applicable) 
5. Date on which the threshold was crossed or reachedvi:21/12/2018
6. Date on which issuer notified (DD/MM/YYYY):24/12/2018
7. Total positions of person(s) subject to the notification obligation
 % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached4.34%2.12%6.47%82,264,881
Position of previous notification (if
applicable)
    



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

ISIN code (if possible)
Number of voting rightsix% of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB00BN40HZ013,572,946 4.34% 
     
     
SUBTOTAL 8. A3,572,9464.34%
 

 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrumentExpiration
date
x
Exercise/
Conversion Period
xi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
American Depositary Shares (ADS)N/AN/A1,750,000 2.12%
     
     
  SUBTOTAL 8. B 11,750,000 2.12%
 

 
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrumentExpiration
date
x
Exercise/
Conversion Period
xi
Physical or cash
settlementxii
Number of voting rights % of voting rights
      
      
      
   SUBTOTAL 8.B.2  
 


9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii 
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
 
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
    
    
    
    
    
 
10. In case of proxy voting, please identify:
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will be held 
 
11. Additional informationxvi
 


Place of completionLondon, UK
Date of completion24/12/2018
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Cathy Lewenberg Steps In as Bevi's New CEO for Growth

Updated Category News Views 411

Bevi, the frontrunner in designing Smart Water Coolers for commercial spaces, appointed Cathy Lewenberg as CEO back in 2024. With her proven track record as the former CEO of Drizly, a major player in North America's alcohol e-commerce scene, she was set to take Bevi through a critical growth phase. The expectation? To leverage her deep roots in the food and beverage...

Continue Reading
Discover Innovations in Technology on Advancements TV Series

Updated Category News Views 206

Catch the Latest Episode of Advancements on Bloomberg Tune in to Bloomberg for an engaging episode of Advancements with Ted Danson, where technology is at the forefront of industry transformation. Exploring the Hydrogen Economy In the upcoming episode, audiences will learn about the significant efforts of the Alliance for Renewable Clean Hydrogen Energy Systems (ARCHES)...

Continue Reading
Interactive Brokers Reports Earnings: Stock Takes 4% Hit

Updated Category News Views 89

Interactive Brokers Q3 Earnings Overview Interactive Brokers Group, Inc. (NASDAQ: IBKR) recently announced its third-quarter earnings report, showcasing a mixed performance that led to a notable decline in its stock price. After the earnings were made public, shares dropped nearly 4% during the after-hours trading session. This reaction highlights the market's sensitivity...

Continue Reading
United Bancshares, Inc. Reports Strong Q4 2025 Financial Growth

Updated Category News Views 101

Highlights of United Bancshares, Inc.'s Fourth Quarter 2025 United Bancshares, Inc. (OTCQX: UBOH), the parent holding company for The Union Bank Company, is excited to share the remarkable financial results for the fourth quarter of 2025. The company has declared a noteworthy quarterly cash dividend of $0.24 per share, showcasing a commitment to delivering value to its...

Continue Reading
Taro Pharmaceutical Faces Lawsuit: Investors Take Action Now

Updated Category News Views 66

Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. Investors in Taro Pharmaceutical Industries Ltd. find themselves at a pivotal moment as a class action lawsuit has been filed against the company. This lawsuit stems from alleged breaches of federal securities laws related to recent developments involving Taro, which trades under the ticker symbol TARO....

Continue Reading